<DOC>
	<DOCNO>NCT00158223</DOCNO>
	<brief_summary>This study ass effectiveness pimozide enhance effect clozapine treatment schizophrenia .</brief_summary>
	<brief_title>Effectiveness Pimozide Augmenting Effects Clozapine Treatment Schizophrenia</brief_title>
	<detailed_description>A significant number schizophrenic exhibit partial response typical antipsychotic medication . Clozapine show effective treat schizophrenia typical antipsychotic drug . However , estimate 30 % 60 % people unresponsive treatment typical antipsychotic respond treatment clozapine . Taking clozapine pimozide , antipsychotic drug , increase clozapine 's effect . However , sufficient research approach yet perform . This study ass effectiveness pimozide enhance effect clozapine treatment schizophrenia . Participants double-blind study receive stable dose clozapine eight week prior enrollment . For first 4 week follow enrollment , baseline measurement take . Once week , participant report study site , symptom severity , cognitive ability , functional status , include read level , assess . In addition , participant receive standard medical examination , include blood test EKG . Upon completion initial phase , participant randomly assign one two treatment group : clozapine combine pimozide ; clozapine combine placebo . This phase last 12 week . Study visit continue occur weekly , use re-assess measurement obtain baseline . In addition , participant EKG study visit first 4 week treatment . All baseline measurement repeat Week 12 .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Pimozide</mesh_term>
	<criteria>Diagnosis schizophrenia accord DSMIV criterion Any schizoaffective disorder subtype Score great 60 Positive Negative Syndrome Scale ( PANSS ) Currently take clozapine Score four high two item positive symptom subscale PANSS Score 4 great Clinical Global Impression ( CGI ) scale Clozapine plasma level great 378 µg/ml Stable dose clozapine demonstrate associated clozapine plasma level great 378 µg/ml least eight week Able read 8th grade level History unstable coronary artery disease Congestive heart failure History long QT syndrome History cardiac arrhythmia History cardiac conduction delay Baseline QT correction score great 0.425 second Liver disease History stroke History Neuroleptic Malignant Syndrome Hypokalemia Hypocalcemia Current blindness , deafness , language difficulty , disability may prevent participation cooperation study Current suicidal homicidal thought Currently abuse psychoactive substance Currently receive antidepressant , thymoleptics , LDOPA , buspirone , antipsychotic clozapine ( Valproic acid Divalproex sodium criterion exclusion )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Clozapine</keyword>
	<keyword>Treatment</keyword>
	<keyword>Combination</keyword>
	<keyword>Unresponsive</keyword>
	<keyword>Schizoaffective Disorders</keyword>
</DOC>